Update on the management of hirsutism

Cleveland Clinic Journal of Medicine

Volumn 77, Issue 6, 2010, Pages 388-398

  Harrison, Shannon ^a   Somani, Najwa ^b   Bergfeld, Wilma F ^c  

^a Dermatologist in private practice   (Australia)

^b INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c LERNER RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ESTHETIC SURGERY; FEMALE; HIRSUTISM; HUMAN; LOW LEVEL LASER THERAPY; METHODOLOGY; REVIEW; PROCEDURES;

FEMALE; HAIR REMOVAL; HIRSUTISM; HUMANS; LASER THERAPY;

EID: 77954675709     PISSN: 08911150     EISSN: None     Source Type: Journal    
DOI: 10.3949/ccjm.77a.08079     Document Type: Review

References (42)

1. Mofid A, Seyyed Alinaghi SA, Zandieh S, Yazdani T. Hirsutism. Int J Clin Pract 2008; 62:433-443.
2. Azziz R, Carmina E, Sawaya ME. Idiopathic hirsutism. Endocr Rev 2000; 21:347-362.
3. Himelein MJ, Thatcher SS. Polycystic ovary syndrome and mental health: a review. Obstet Gynecol Surv 2006; 61:723-732.
4. Williamson K, Gunn AJ, Johnson N, Milsom SR. The impact of ethnicity on the presentation of polycystic ovarian syndrome. Aust N Z J Obstet Gynaecol 2001; 41:202-206.
5. Diamanti-Kandarakis E, Kouli CR, Bergiele AT, et al. A survey of the polycystic ovary syndrome in the Greek island of Lesbos: hormonal and metabolic profile. J Clin Endocrinol Metab 1999; 84:4006-4011.
6. Ferriman D, Gallwey JD. Clinical assessment of body hair growth in women. J Clin Endocrinol Metab 1961; 21:1440-1447.
7. Messenger AG. The control of hair growth: an overview. J Invest Dermatol 1993; 101(suppl 1):4S-9S.
8. Rosenfield RL. Hirsutism and the variable response of the pilosebaceous unit to androgen. J Investig Dermatol Symp Proc 2005; 10:205-208.
9. Longcope C. Adrenal and gonadal androgen secretion in normal females. Clin Endocrinol Metab 1986; 15:213-228.
10. Braunstein GD. Testis. In: Gardner DG, Shoback D, editors. Greenspan's Basic & Clinical Endocrinology. 8th ed. New York: McGraw-Hill, 2007.
11. Deplewski D, Rosenfield RL. Role of hormones in pilosebaceous unit development. Endocr Rev 2000; 21:363-392.
12. Practice Committee of the American Society for Reproductive Medicine. The evaluation and treatment of androgen excess. Fertil Steril 2006; 86(suppl 5):S241-S247.
13. Azziz R, Waggoner WT, Ochoa T, Knochenhauer ES, Boots LR. Idiopathic hirsutism: an uncommon cause of hirsutism in Alabama. Fertil Steril 1998; 70:274-278.
14. Rossi R, Tauchmanovà L, Luciano A, et al. Functional hyperandrogenism detected by corticotropin and GnRH-analogue stimulation tests in women affected by ap-parently idiopathic hirsutism. J Endocrinol Invest 2001; 24:491-498.
15. Rosenfield RL. Clinical practice. Hirsutism. N Engl J Med 2005; 353:2578-2588.
16. Rotterdam ESHRE/ASRM-Sponsored PCOS consensus workshop group. Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS). Hum Reprod 2004; 19:41-47
17. Salley KE, Wickham EP, Cheang KI, Essah PA, Karjane NW, Nestler JE. Glucose intolerance in polycystic ovary syndrome-a position statement of the Androgen Excess Society. J Clin Endocrinol Metab 2007; 92:4546-4556
18. Eckel RH, Grundy SM, Zimmet PZ. The metabolic syndrome. Lancet 2005; 365:1415-1428.
19. Azziz R. Diagnostic criteria for polycystic ovary syn-drome: a reappraisal. Fertil Steril 2005; 83:1343-1346
20. Orfanos CE, Adler YD, Zouboulis CC. The SAHA syndrome. Horm Res 2000; 54:251-258.
21. New MI. Extensive clinical experience: nonclassical 21-hydroxylase deficiency. J Clin Endocrinol Metab 2006; 91:4205-4214.
22. Kohn B, Levine LS, Pollack MS, et al. Late-onset steroid 21-hydroxylase deficiency: a variant of classical congenital adrenal hyperplasia. J Clin Endocrinol Metab 1982; 55:817-827.
23. Knochenhauer ES, Hines G, Conway-Myers BA, Azziz R. Examination of the chin or lower abdomen only for the prediction of hirsutism. Fertil Steril 2000; 74:980-983.
24. Somani N, Harrison S, Bergfeld WF. The clinical evaluation of hirsutism. Dermatol Ther 2008; 21:376-391.
25. Waggoner W, Boots LR, Azziz R. Total testosterone and DHEAS levels as predictors of androgen-secreting neoplasms: a populational study. Gynecol Endocrinol 1999; 13:394-400.
26. Crapo L. Cushing's syndrome: a review of diagnostic tests. Metabolism 1979; 28:955-977.
27. Blethen SL, Chasalow FI. Overnight dexamethasone suppression test: normal responses and the diagnosis of Cushing's syndrome. Steroids 1989; 54:185-193.
28. Bertagna C, Orth DN. Clinical and laboratory findings and results of therapy in 58 patients with adrenocortical tumors admitted to a single medical center (1951 to 1978). Am J Med 1981; 71:855-875.
29. Kologlu S, Baskal N, Kologlu LB, Laleli Y, Tuccar E. Hirsutism due to the treatment with L-thyroxine in patients with thyroid pathology. Endocrinologie 1988; 26:179-185.
30. Gambineri A, Patton L, Vaccina A, et al. Treatment with flutamide, metformin, and their combination added to a hypocaloric diet in overweight-obese women with polycystic ovary syndrome: a randomized, 12-month, placebo-controlled study. J Clin Endocrinol Metab 2006; 91:3970-3980.
31. Dawber RP. Guidance for the management of hirsutism. Curr Med Res Opin 2005; 21:1227-1234.
32. Haedersdal M, Wulf HC. Evidence based review of hair removal using lasers and light sources. J Eur Acad Dermatol Venereol 2006; 20:9-20.
33. Sadighha A, Mohaghegh Zahed G. Meta-analysis of hair removal laser trials. Lasers Med Sci 2009; 24:21-25.
34. Casey AS, Goldberg D. Guidelines for laser hair removal. J Cosmet Laser Ther 2008; 10:24-33.
35. Wakelin SH, Maibach Hi, editors. Handbook of Systemic Drug Treatment in Dermatology. London: Manson Publishing Ltd, 2004.
36. Swiglo BA, Cosma M, Flynn DN, et al. Clinical review: antiandrogens for the treatment of hirsutism: a systematic review and metaanalyses of randomized controlled trials. J Clin Endocrinol Metab 2008; 93:1153-1160.
37. Cosma M, Swiglo BA, Flynn DN, et al. Clinical review: insulin sensitizers for the treatment of hirsutism: a systematic review and metaanalyses of randomized controlled trials. J Clin Endocrinol Metab 2008; 93:1135-1142.
38. Balfour JA, McClellan K. Topical eflornithine. Am J Clin Dermatol 2001; 2:197-201.
39. Wolf JE Jr, Shander D, Huber F, et al; Eflornithine HCl Study Group. Randomized, double-blind clinical evaluation of the efficacy and safety of topical eflornithine HCl 13.9% cream in the treatment of women with facial hair. Int J Dematol 2007; 46:94-98.
40. Hamzavi I, Tan E, Shapiro J, Lui H. A randomized bilateral vehicle-controlled study of eflornithine cream combined with laser treatment versus laser treatment alone for facial hirsutism in women. J Am Acad Dermatol 2007; 57:54-59.
41. Van der Spuy ZM, le Roux PA. Cyproterone acetate for hirsutism. Cochrane Database Syst Rev 2003; 4:CD001125.